Active immunisation targeting nerve growth factor attenuates chronic pain behaviour in murine osteoarthritis
von Loga IS. et al, (2019), Annals of the Rheumatic Diseases, 78, 672 - 675
Active vaccination against interleukin-5 as long-term treatment for insect-bite hypersensitivity in horses
Fettelschoss-Gabriel A. et al, (2019), Allergy, 74, 572 - 582
A vaccine against Alzheimer`s disease: anything left but faith?
Bachmann MF. et al, (2019), Expert Opinion on Biological Therapy, 19, 73 - 78
The 5th virus-like particle and nano-particle vaccines (VLPNPV) conference
Engeroff P. and Bachmann MF., (2019), Expert Review of Vaccines, 18, 1 - 3
Induction of Human T-cell and Cytokine Responses Following Vaccination with a Novel Influenza Vaccine
Skibinski DAG. et al, (2018), Scientific Reports, 8
Virus-like particles (VLP) in prophylaxis and immunotherapy of allergic diseases
Klimek L. et al, (2018), Allergo Journal International, 27, 245 - 255
An unexpected protective role of low-affinity allergen-specific IgG through the inhibitory receptor FcγRIIb
Zha L. et al, (2018), Journal of Allergy and Clinical Immunology, 142, 1529 - 1536.e6
The Prospects of an Active Vaccine Against Asthma Targeting IL-5
Bachmann MF. et al, (2018), Frontiers in Microbiology, 9
Treating insect-bite hypersensitivity in horses with active vaccination against IL-5
Fettelschoss-Gabriel A. et al, (2018), Journal of Allergy and Clinical Immunology, 142, 1194 - 1205.e3
A novel recycling mechanism of native IgE-antigen complexes in human B cells facilitates transfer of antigen to dendritic cells for antigen presentation
Engeroff P. et al, (2018), Journal of Allergy and Clinical Immunology, 142, 557 - 568.e6
Biosensor-based selective detection of Zika virus specific antibodies in infected individuals
Cabral-Miranda G. et al, (2018), Biosensors and Bioelectronics, 113, 101 - 107
Interaction of Viral Capsid-Derived Virus-Like Particles (VLPs) with the Innate Immune System
Mohsen M. et al, (2018), Vaccines, 6, 37 - 37
Vaccination against IL-31 for the treatment of atopic dermatitis in dogs
Bachmann MF. et al, (2018), Journal of Allergy and Clinical Immunology, 142, 279 - 281.e1
Allergens displayed on virus-like particles are highly immunogenic but fail to activate human mast cells
Engeroff P. et al, (2018), Allergy, 73, 341 - 349
Incorporation of tetanus-epitope into virus-like particles achieves vaccine responses even in older recipients in models of psoriasis, Alzheimer’s and cat allergy
Zeltins A. et al, (2017), npj Vaccines, 2
Nanoassembly routes stimulate conflicting antibody quantity and quality for transmission-blocking malaria vaccines
Leneghan DB. et al, (2017), Scientific Reports, 7
Microcrystalline Tyrosine (MCT®): A Depot Adjuvant in Licensed Allergy Immunotherapy Offers New Opportunities in Malaria
Cabral-Miranda G. et al, (2017), Vaccines, 5, 32 - 32
Preclinical development of a vaccine against oligomeric alpha-synuclein based on virus-like particles
Doucet M. et al, (2017), PLOS ONE, 12, e0181844 - e0181844
Therapeutic silence of pleiotrophin by targeted delivery of siRNA and its effect on the inhibition of tumor growth and metastasis
Zha L. et al, (2017), PLOS ONE, 12, e0177964 - e0177964